Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | GPR35 | Q9HC97 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.36 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.36 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.36 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8938816 | 0.82 | TDP1 (0.35) | TSHRGPR35TDP1ATMALDH1A1 | |
| SCHEMBL27650277 | 0.78 | TDP1 (0.41) | TSHRGPR35TDP1ATMALDH1A1 | |
| SCHEMBL18478 | 0.78 | TSHR (0.42) | TSHRGPR35TDP1ATMALDH1A1 | |
| SCHEMBL11049111 | 0.76 | TSHR (0.41) | TSHRGPR35TDP1ALDH1A1TXNRD1 | |
| SCHEMBL2289877 | 0.76 | TSHR (0.50) | TSHRGPR35TDP1ALDH1A1TXNRD1 | |
| SCHEMBL3888842 | 0.76 | GPR35 (0.50) | TSHRGPR35TDP1ALDH1A1HIF1A | |
| SCHEMBL7646278 | 0.76 | TSHR (0.38) | TSHRGPR35TDP1ALDH1A1HIF1A | |
| SCHEMBL2075134 | 0.73 | TDP1 (0.45) | TSHRGPR35TDP1ATMALDH1A1 | |
| SCHEMBL4310749 | 0.73 | BCHE (0.40) | TSHRGPR35TDP1ATMALDH1A1 | |
| SCHEMBL8011546 | 0.73 | ALDH1A1 (0.44) | TDP1ALDH1A1MEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210130676-A1 | CROSS-LINKED POLYROTAXANES AND THEIR APPLICATION IN CEMENT | SAUDI ARABIAN OIL COMPANY (SA) | 2021-05-06 | — | — | US | claimed |
| WO-2021087048-A1 | CROSS-LINKED POLYROTAXANES AND THEIR APPLICATION IN CEMENT | SAUDI ARABIAN OIL COMPANY (SA) | 2021-05-06 | — | — | WO | claimed |
| EP-1658503-B1 | CHEMILUMINESCENT COMPOUNDS | MOLECULAR LIGHT TECH RES LTD (GB) | 2009-11-18 | — | — | EP | claimed |
| US-20070166759-A1 | Chemiluminescent compounds | GEN-PROBE CARDIFF, LTD. (GB) | 2007-07-19 | — | — | US | claimed |
| EP-1658503-A1 | CHEMILUMINESCENT COMPOUNDS | Molecular Light Technology Research Limited (GB) | 2006-05-24 | — | — | EP | claimed |
| WO-2005022161-A1 | CHEMILUMINESCENT COMPOUNDS | MOLECULAR LIGHT TECHNOLOGY RESEARCH LIMITED (GB) | 2005-03-10 | — | — | WO | claimed |
| WO-2000035865-A2 | TUBULIN-BINDING AGENTS | TULARIK INC. (US) | 2000-06-22 | — | — | WO | claimed |
| US-20240222102-A1 | APOLIPOPROTEIN E ISOTYPE DETECTION BY MASS SPECTROMETRY | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-07-04 | — | — | US | disclosed |
| CN-118225957-A | Method for detecting chromogranin A by mass spectrometry | 奎斯特诊断投资有限公司 | 2024-06-21 | — | — | CN | disclosed |
| US-20240168039-A1 | METHODS FOR DETECTING VITAMIN D METABOLITES BY MASS SPECTROMETRY | QUEST DIAGNOSTICS INVEST LLC (US) | 2024-05-23 | — | — | US | disclosed |
| CN-112119310-B | Method for detecting chromogranin A by mass spectrometry | 奎斯特诊断投资有限公司 | 2024-04-09 | — | — | CN | disclosed |
| US-20240110899-A1 | METHODS FOR DETECTING CHROMOGRANIN A BY MASS SPECTROMETRY | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-04-04 | — | — | US | disclosed |
| CN-117761323-A | Detection of amyloid beta by mass spectrometry | 奎斯特诊断投资有限公司 | 2024-03-26 | — | — | CN | disclosed |
| EP-0592242-A1 | Fibrin sealant compositions and method for utilizing same | E.R. SQUIBB & SONS, INC. (US) | 1994-04-13 | — | — | EP | disclosed |
| EP-0562373-A2 | Immobilisation of biochemical substances | SIEMENS AKTIENGESELLSCHAFT (DE) | 1993-09-29 | — | — | EP | disclosed |
| EP-0562370-A2 | Biosensor | SIEMENS AKTIENGESELLSCHAFT (DE) | 1993-09-29 | — | — | EP | disclosed |
| EP-0562371-A2 | Immobilisation of biochemical substances | SIEMENS AKTIENGESELLSCHAFT (DE) | 1993-09-29 | — | — | EP | disclosed |
| EP-0562372-A2 | Biosensor | SIEMENS AKTIENGESELLSCHAFT (DE) | 1993-09-29 | — | — | EP | disclosed |
| US-5183749-A | One step fermentation for carrying out hydroxylation or epoxidation or both reactions | SANKYO COMPANY, LTD. (JP) | 1993-02-02 | — | — | US | disclosed |
| EP-0356384-A2 | Recycling of sulfuric-acid waste with the aid of a biological process | CIBA-GEIGY AG (CH) | 1990-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166759-A1 | Chemiluminescent compounds | CBR3, CBR1, LTC4S | TSHR 127/4885GPR35 1168/4885TDP1 2662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.